NAD+ Supplements and IV Therapy — What the Evidence Actually Shows

You've probably seen NAD+ marketed as an anti-aging miracle. You've probably also seen someone online saying it's all hype. Both camps exist. Both have PhDs.

Here's what's actually happening: the biology is genuinely compelling, the human evidence is limited, and the supplement market is a regulatory mess. Understanding which part is which changes everything about how you approach this.

This is the honest breakdown — what NAD+ does, what the research actually shows, which precursors are legal, what IV therapy involves, and when any of this is worth spending money on.

What NAD+ Does in Your Body

NAD+ stands for nicotinamide adenine dinucleotide. Without it, nothing works. It's a coenzyme involved in over 500 enzymatic reactions — energy production, DNA repair, cell signaling, the works. Every cell in your body except red blood cells depends on it (Sauve, 2008). NAD+ is structurally related to vitamin B3 and niacin — the same family of precursor molecules that feed into cellular energy pathways.

The reason it matters for aging specifically comes down to two things.

First: NAD+ levels fall with age. Measurably, across tissues. A study comparing skin samples from newborns to adults in their 70s found that NAD+ levels decline progressively as age increases, correlating with increased DNA damage (Yoshino et al., 2017). That's a human finding, not a mouse finding.

Second: sirtuins. These are NAD+-dependent proteins that regulate DNA repair, metabolism, and stress resistance (Cantó et al., 2009). SIRT1 protects against metabolic syndrome and vascular dysfunction. SIRT3 is protective against dyslipidemia and cardiac injury. Sirtuin activity declines with age, obesity, and sedentary lifestyle — and NAD+ is the fuel they run on (Kane & Sinclair, 2018).

There's also PARP1, a DNA repair enzyme. When NAD+ levels are sufficient, PARP1 works properly. As NAD+ declines, so does DNA repair capacity. Li et al. (2017) demonstrated this in Science — declining NAD+ allows a protein called DBC1 to bind and inhibit PARP1, causing DNA damage to accumulate. Restoring NAD+ rapidly reversed the effect in mice.

The mechanism is real. The question is whether you can meaningfully boost NAD+ in a living human by taking a pill or getting an IV drip — and whether that matters for how you feel and age.

The Precursor Problem: NMN, NR, and a Regulatory Nightmare

You can't take NAD+ directly and have it work well. It doesn't cross cell membranes efficiently. So researchers identified precursors — molecules your body converts into NAD+.

Two dominate the conversation: NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside). They're different molecules that travel different pathways to get to NAD+.

Here's where things get complicated.

NMN: Biologically Promising, Legally Gray

NMN is the molecule David Sinclair, PhD — a Harvard geneticist and author of Lifespan — takes daily (Sinclair, 2022). He's been public about it for years: 1g NMN every morning, with resveratrol. He's described doubling NAD+ blood levels in study participants after two weeks of supplementation (Sinclair, 2022 podcast discussion).

The animal data supporting NMN is substantial. In mouse models, NMN supplementation has improved energy metabolism, insulin sensitivity, muscle function, and age-associated physical decline across multiple studies (Hong et al., 2020). These are real effects in real mammals.

The human data is much thinner.

One Chinese randomized controlled trial (n=80, NCT06966583) found that 600 mg daily NMN improved walking distance by 50% and well-being scores by 15% in middle-aged adults compared to placebo (Hong et al., 2020). That's promising. But it's one study, not yet peer-reviewed at the time of the Reddit discussion that circulated it widely.

Then there's the regulatory problem. In 2022, the FDA effectively banned NMN from being sold as a dietary supplement in the United States. A company called Metro International Biotech filed an Investigational New Drug (IND) application for NMN (IND 138975). Under 21 USC 321(ff)(3)(B), a substance that has an active IND cannot be marketed as a dietary supplement. The FDA sent warning letters to companies selling NMN supplements in 2022-2023.

As of April 2026, this policy has not been reversed.

NMN products still appear online. Companies that haven't received warning letters continue selling. That's a gray market, not a legal supplement.

NR: The One That's Actually Legal

Nicotinamide riboside is the precursor that remains fully legal as a dietary supplement in the United States. ChromaDex's Tru Niagen has FDA Generally Recognized as Safe (GRAS) status and filed new dietary ingredient (NDI) notifications. It's been through more human clinical testing than NMN.

The human evidence for NR shows one consistent finding: it raises blood NAD+ levels. Multiple trials have confirmed this. That's not nothing.

What's less clear is whether raising blood NAD+ via NR translates to meaningful health outcomes. This is where smart people genuinely disagree.

Rhonda Patrick, PhD (FoundMyFitness) has remained cautiously optimistic — she supports NR and NMN for NAD restoration but consistently emphasizes that exercise remains the most potent NAD+ booster we know of, with the strongest evidence base.

Peter Attia, MD publicly walked back his position on NR. He's stated he stopped taking it after reviewing the evidence — NR failed to extend lifespan in the NIH's Interventions Testing Program (ITP), a rigorous multi-site animal study, and some research raised concerns about NR potentially accelerating cancer growth in certain contexts.

Brad Stanfield, MD — a New Zealand GP who carefully tracks the longevity literature — reversed his positive stance on NMN specifically after reviewing the accumulating evidence that the benefits in animal models weren't translating clearly to humans.

Charles Brenner, the University of Iowa researcher who discovered NR, has been even more direct: NAD boosting helps resilience, he says, but doesn't stop or reverse aging. And resveratrol combined with NMN, the protocol Sinclair is famous for, is "useless or maybe dangerous" in his assessment.

This is what real scientific disagreement looks like. Not supplement-brand marketing. Credentialed researchers who have reviewed the same literature and reached different conclusions.

What does this tell you? The mechanism is sound. The human evidence is genuinely limited. Two human RCTs in the broader context of compelling animal data is a small foundation.

What the Human Research Actually Shows

To be clear about where the evidence stands: there have been limited human randomized controlled trials on NMN or NR supplementation for the anti-aging outcomes people care about.

Blood NAD+ elevation: consistent finding. NR reliably raises whole blood NAD+ levels. One open-label study (NCT03707652, n=8) assessed different supplement combinations for increasing NAD+ levels, finding measurable increases (Guan et al., 2017). NR at doses of 250-1000 mg daily consistently elevates NAD+ in human blood (Yoshino et al., 2017).

Exercise tolerance: the Chinese NMN trial (n=80, 600mg daily, 30-90 days) showed a 50% improvement in six-minute walk distance and significant quality-of-life improvements in middle-aged adults (40-65). This is one of the few positive human RCTs with functional outcomes.

Muscle function in Li-Fraumeni Syndrome (a rare genetic condition): one NIH-sponsored trial (NCT03789175) used NR in a single patient to study skeletal muscle energy recovery (Braidy & Grant, 2017). This is a n=1 case study, not generalizable.

Trauma recovery in elderly patients: a Phase I trial (NCT03635411, n=48, sponsored by Elysium Health) tested NR and pterostilbene in elderly trauma patients. Results are not publicly completed.

Cardiovascular research remains at the preclinical stage. NAD+ replenishment suppressed cardiac hypertrophy and improved function in animal models (Lee et al., 2016). A 2021 review in Circulation found that NAD+ precursors show real promise for cardiac and metabolic disease but noted that clinical trial design challenges remain (Abdellatif et al., 2021). Human trials are in progress.

The gap between the preclinical data and the clinical evidence is not a sign that NAD+ doesn't matter. It reflects how difficult and expensive these trials are, and how early we are in this research cycle.

What we can say honestly: NR raises blood NAD+. A small body of human data suggests functional improvements at higher doses. The animal data predicts meaningful health benefits. We don't yet have the long-term human trials that would confirm this.

NAD+ IV Therapy: The Fastest Way Up

Oral supplements raise NAD+ gradually. IV therapy takes a different approach.

NAD+ administered intravenously bypasses the digestive system entirely. It reaches the bloodstream directly, producing rapid increases in circulating NAD+. Craig Koniver, MD — a hormone and peptide specialist who has appeared on the Huberman Lab podcast — uses NAD+ IV therapy with patients in clinical practice and reports positive responses in fatigue, cognitive function, and recovery.

The reported benefits from clinical use include energy restoration (particularly in patients with chronic fatigue or post-COVID), improved mental clarity, accelerated recovery from addiction or withdrawal, and enhanced athletic performance recovery.

The experience itself is notable: NAD+ IV infusions are known to be uncomfortable at high drip rates. Nausea, flushing, and chest tightness are commonly reported during the infusion itself. Most clinics slow the drip rate when symptoms appear.

There are 8 adverse event reports in the FDA FAERS database for NAD+ preparations. Reported reactions included erectile dysfunction (2 cases), hyponatremia, hypokalemia, hypomagnesemia, drug interaction concerns, paresthesia, tendon pain, muscle twitching, nerve injury, and gait disturbance. Eight reports from a therapy used widely across longevity clinics nationally is a low signal — but these are the known safety flags to be aware of.

NAD+ IV drips are compounded preparations — not FDA-approved drugs. They're legally administered in clinical settings under 503A pharmacy compounding. This is similar to how many peptides and hormone therapies work: physician-prescribed, pharmacy-compounded, administered in a clinical context.

For athletes: WADA regulations prohibit IV infusions of any substance exceeding 100mL per 12-hour period under M2 (Chemical and Physical Manipulation), regardless of the substance. Athletes using NAD+ IV therapy should confirm volume compliance. For broader context on supplements and athletic performance, see our guide to B12 injections for energy and recovery.

NMN vs NR: The Practical Decision

If you're considering NAD+ precursor supplementation, here's where the practical decision lands as of April 2026.

Factor	NMN	NR (Tru Niagen)
US Legal Status	Effectively banned as supplement (FDA IND exclusion)	Legal supplement with NDI status
Human Evidence	Very limited (1-2 trials)	Consistent blood NAD+ elevation; functional data mixed
Expert Stance	Sinclair: takes 1g daily; Stanfield: reversed positive view	Attia: stopped taking; Patrick: cautiously supportive
Cost	~$40-80/month (gray market)	~$50-80/month (Tru Niagen)
Bioavailability	Good — converts to NR or directly to NAD+ depending on tissue	Solid — well-studied pathway

The honest answer is that neither has strong enough human evidence to call definitively. If you want the legal option with more human safety data, NR via Tru Niagen is the reasonable choice. If you want the option currently favored by the most prominent longevity researchers despite its regulatory status, that's NMN — with full understanding that you're buying from a legal gray market.

Both are outperformed by exercise for raising NAD+. That's not a dodge — it's the most consistent finding across the research.

What This Costs and How to Access It

Oral Supplements

NMN (gray market): $40-80/month at 500-1000mg dosing. Quality varies significantly — third-party purity testing matters here.

NR via Tru Niagen: $50-80/month at 300-600mg. ChromaDex's product has the most established safety record and human study participation of any NAD+ precursor supplement.

Insurance does not cover either. These are cash-pay supplements with no insurance pathway.

NAD+ IV Therapy

NAD+ IV drips in clinical settings typically run $200-400 per session. Higher-dose or premium clinic pricing can reach $600-1000 per session. Most longevity protocols recommend a series of 3-5 initial infusions, then maintenance sessions monthly or quarterly.

Insurance does not cover NAD+ IV therapy. It is administered as a compounded preparation in functional medicine and longevity clinic settings.

Through HEXIS

HEXIS offers NAD+ IV therapy administered by licensed providers. Your protocol begins with labs — we can measure your actual NAD+ levels before you spend money on any form of supplementation. Knowing your baseline changes the calculus: if your NAD+ is already in a reasonable range, the marginal benefit of aggressive supplementation is different than if you're significantly depleted.

After your initial blood panel, your HEXIS provider will review where you stand and whether oral precursors, periodic IV therapy, or both make sense given your goals, health status, and budget.

Schedule a consultation to discuss NAD+ IV therapy and supplementation options.

Should You Take NAD+ Supplements?

That depends on what you're trying to accomplish, how you weight limited evidence, and what your actual baseline looks like.

Here's a reasonable framework:

If you're primarily interested in energy and general health: exercise first. Seriously. The data for exercise raising NAD+ and activating sirtuins is stronger than any supplement data. If you're already exercising consistently and want to add a precursor, NR (Tru Niagen) is the legally clear, best-studied option. Some providers also combine NAD+ protocols with vitamin D3 and B-vitamin support for a more complete mitochondrial foundation.

If you're interested in aging biology specifically and willing to accept limited human evidence: the mechanistic rationale for NAD+ precursors is sound. Sinclair's work on sirtuin activation and the role of NAD+ in DNA repair (Li et al., 2017) isn't pseudoscience. Whether supplement doses in healthy humans produce measurable longevity benefits hasn't been proven. But neither has it been ruled out.

If you're experiencing significant fatigue, brain fog, or recovery issues: this is where testing matters most. Functional decline can stem from many directions. Measuring your actual NAD+ levels before committing to a protocol is the physician-guided approach — not guesswork.

If you want the fastest and most direct NAD+ restoration: IV therapy bypasses oral bioavailability concerns entirely. It's more expensive and requires a clinical visit. For patients with specific recovery goals or who have tried oral supplementation without results, IV therapy is the logical next step.

FAQ

Is NMN legal to buy in the United States?

NMN is effectively banned from being sold as a dietary supplement in the US. The FDA's position is that NMN cannot be marketed as a dietary supplement because Metro International Biotech filed an active Investigational New Drug application (IND 138975) for the compound. Under federal law, substances with active INDs are excluded from the dietary supplement market. NMN products still appear for sale online, but companies selling them risk FDA warning letters. NR (nicotinamide riboside) remains a legal US dietary supplement.

How much does NAD+ IV therapy cost, and is it covered by insurance?

NAD+ IV therapy costs $200-1000 per session depending on the clinic and dosing protocol. Insurance does not cover it — it is administered as a compounded preparation, not an FDA-approved drug. Most longevity clinics recommend an initial series of 3-5 sessions, then quarterly maintenance. At HEXIS, we work with you to build a protocol that makes sense for your goals and budget.

What are the side effects of NAD+ IV therapy?

The most common side effect is discomfort during the infusion itself — nausea, flushing, chest tightness, and a sense of heat. These are typically managed by slowing the drip rate. The FDA's FAERS adverse event database has 8 serious adverse event reports associated with NAD+ preparations. These include electrolyte disturbances, nerve symptoms, and muscle effects. Working with a licensed clinical provider rather than attempting IV therapy through unregulated means matters for safety.

Does NAD+ actually slow aging in humans?

The honest answer is: we don't know yet. The mechanistic case is compelling — NAD+ declines with age, sirtuins and DNA repair depend on it, and restoring NAD+ reverses age-related changes in animal models. Human evidence is limited to a small number of trials showing elevated blood NAD+ and some functional improvements. Long-term aging outcomes in humans haven't been studied. The researchers who know this field best disagree about whether current supplementation strategies translate to meaningful longevity benefits.

Which is better for anti-aging: NMN or NR?

There's no clear answer from human trials. Both raise blood NAD+. NMN has more prominent advocates (David Sinclair) but is legally unavailable as a US supplement and has less human safety data than NR. NR has more human clinical study participation and is legally available. Experts including Peter Attia and Brad Stanfield have walked back earlier enthusiasm for NR specifically. If you're choosing between them, NR via Tru Niagen is the legally clear, better-studied option. Your actual baseline NAD+ level matters more than which precursor you choose — measuring before supplementing is the physician-guided approach.

The Bottom Line

NAD+ is a real and important molecule (Sauve, 2008). Its decline with age is a real phenomenon. The sirtuins and DNA repair pathways that depend on it are genuinely promising therapeutic targets (Yoshino et al., 2017).

The supplements are ahead of the evidence. NR works at raising blood NAD+. NMN appears to as well. Whether that translates to meaningful human health outcomes — slower aging, better energy, improved function over years — is not yet established in clinical trials.

What makes HEXIS's approach different is that we don't ask you to guess. We measure. Your NAD+ levels, your hormonal baseline, your full panel. Then we build a protocol around what your body actually shows, not what's trending in the longevity podcast world.

If you're serious about NAD+ optimization, start with a physician-guided consult. Know your numbers. Then decide.

Schedule a consultation at HEXIS to discuss NAD+ supplements and IV therapy with a licensed provider.

---